These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3888307)
1. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation. Leonard JE; Taetle R; To D; Rhyner K Blood; 1985 May; 65(5):1149-57. PubMed ID: 3888307 [TBL] [Abstract][Full Text] [Related]
2. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins. Stong RC; Youle RJ; Vallera DA Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999 [TBL] [Abstract][Full Text] [Related]
3. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275 [TBL] [Abstract][Full Text] [Related]
4. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation. Stong RC; Uckun F; Youle RJ; Kersey JH; Vallera DA Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347 [TBL] [Abstract][Full Text] [Related]
5. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation. Douay L; Gorin NC; Lopez M; Casellas P; Liance MC; Jansen FK; Voisin GA; Baillou C; Laporte JP; Najman A Cancer Res; 1985 Jan; 45(1):438-41. PubMed ID: 3880666 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model. Weil-Hillman G; Runge W; Jansen FK; Vallera DA Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376 [TBL] [Abstract][Full Text] [Related]
7. Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Preijers FW; De Witte T; Wessels JM; De Gast GC; Van Leeuwen E; Capel PJ; Haanen C Blood; 1989 Aug; 74(3):1152-8. PubMed ID: 2473811 [TBL] [Abstract][Full Text] [Related]
8. Antigenic modulation by anti-CD5 immunotoxins. Manske JM; Buchsbaum DJ; Azemove SM; Hanna DE; Vallera DA J Immunol; 1986 Jun; 136(12):4721-8. PubMed ID: 3086441 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates. Leonard JE; Wang QC; Kaplan NO; Royston I Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T cells in bone marrow. Preijers FW; De Witte T; Wessels JM; Meyerink JP; Haanen C; Capel PJ Br J Haematol; 1989 Feb; 71(2):195-201. PubMed ID: 2784323 [TBL] [Abstract][Full Text] [Related]
12. Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin. Siena S; Villa S; Bregni M; Bonnadonna G; Gianni AM Blood; 1987 Jan; 69(1):345-8. PubMed ID: 3098324 [TBL] [Abstract][Full Text] [Related]
13. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin. Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970 [TBL] [Abstract][Full Text] [Related]
14. Immunotoxins show rapid entry of diphtheria toxin but not ricin via the T3 antigen. Youle RJ; Uckun FM; Vallera DA; Colombatti M J Immunol; 1986 Jan; 136(1):93-8. PubMed ID: 3079613 [TBL] [Abstract][Full Text] [Related]
15. Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells. Roy DC; Griffin JD; Belvin M; Blättler WA; Lambert JM; Ritz J Blood; 1991 Jun; 77(11):2404-12. PubMed ID: 2039821 [TBL] [Abstract][Full Text] [Related]
16. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related]
17. Optimal elimination of leukemic T cells from human bone marrow with T101-ricin A-chain immunotoxin. Casellas P; Canat X; Fauser AA; Gros O; Laurent G; Poncelet P; Jansen FK Blood; 1985 Feb; 65(2):289-97. PubMed ID: 3871341 [TBL] [Abstract][Full Text] [Related]
18. T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease. Fauser AA; Shustik C; Langleben A; Laurent G; Kanz L; Spurll GM; Price G; Ahlgren PD; Cooper BA Clin Invest Med; 1988 Feb; 11(1):40-6. PubMed ID: 3284672 [TBL] [Abstract][Full Text] [Related]
19. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow. Filipovich AH; Vallera DA; Youle RJ; Haake R; Blazar BR; Arthur D; Neville DM; Ramsay NK; McGlave P; Kersey JH Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain. Vallera DA; Quinones RR; Azemove SM; Soderling CC Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]